NEUROENDOCRINE CANCER UK
1. To advance the education of the general public (including relevant medical and scientific communities) in all areas relating to NETs.2. To promote the physical and mental health of those affected by NETs through the provision of support, advice and education to patients, carers and family members.
Objects
1. TO ADVANCE THE EDUCATION OF THE GENERAL PUBLIC (INCLUDING RELEVANT MEDICAL AND SCIENTIFIC COMMUNITIES) IN ALL AREAS RELATING TO NETS. 2. TO PROMOTE THE PHYSICAL AND MENTAL HEALTH OF THOSE AFFECTED BY NETS THROUGH THE PROVISION OF SUPPORT, ADVICE AND EDUCATION TO PATIENTS, THEIR CARERS AND FAMILY MEMBERS
Financial health, per its FY2025 accounts
The accounts state that the charity reported a surplus of £128,305 for the year ended 30 September 2025, with total funds carried forward reaching £1,117,726. The trustees confirm that these reserves are sufficient to support planned activities for the next 12 months, noting a reserves policy target of covering 1.5 to 2 years' budgeted regular operating costs. The charity is entirely reliant on donations and grants for income, with no disclosed trading subsidiaries or pension deficits.
What the accounts disclose
“Our reserves policy is to keep reserves to cover 1.5 to 2 years' budgeted regular operating costs”
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Structured financials (annual return, FY ending 30/09/2025)
Register events
- Received assets from another charity (06/09/2023)
Trustees
- PETER HOWARD GWILLIAMchair
- DAVID JOHN AMES
- Dr GORDON BROWN
- Dr Rajaventhan Srirajaskanthan
- Emma Brown
- JOHN MICHAEL KENT
- Tom Peter Jackson
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £696k | £567k |
| 30/09/2024 | £720k | £481k |
| 30/09/2023 | £492k | £431k |
| 30/09/2022 | £399k | £388k |
| 30/09/2021 | £576k | £361k |
Common questions
Is NEUROENDOCRINE CANCER UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a surplus of £128,305 for the year ended 30 September 2025, with total funds carried forward reaching £1,117,726. The trustees confirm that these reserves are sufficient to support planned activities for the next 12 months, noting a reserves policy target of covering 1.5 to 2 years' budgeted regular operating costs. The charity is entirely reliant on donations and grants for income, with no disclosed trading subsidiaries or pension deficits. Its FY2025 accounts were independently examined.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | 30/06/2020 | £8k | Coronavirus Community Support Fund |